Newsletter
Decentralized: The Decentralized Trials & Research Podcast

Decentralized: The Decentralized Trials & Research Podcast

A space for all who want to improve access for clinical research and participation.

Data from the Field: DCT Participant Experience

2023-09-22 Our host Jane Myles was joined by Ingrid Oakley-Girvan with Medable to share data from the field around the DCT Participant Experience and her perspectives as a physician in the field.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
September 25, 2023

DTRA Circles Round Up

2023-09-08 Join us to hear about all things DTRA Circles. These functional collaboration groups were built around areas of interest for our members, such as Diversity, Data Management, Patient Voice, and more. Sarah McKeown-Cannon and Deena Bernstein joined us for the conversation.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
September 11, 2023

Partnering PI Networks + DCT Platforms

2022-01-28 What comes from bringing together networks of investigators with established technology platforms in the space? Our hosts Craig Lipset and Amir Kalali were joined by Kelly McKee (Medidata) and Irfan Khan (Circuit Clinical) for the conversation.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
September 1, 2023

Can Patients Bring Their EHR Data into DCTs Today?

2022-05-13 Join us to hear from Ardy Arianpour (SEQSTER) and Marjorie Tan-Thronson (Salesforce) to hear about the use case, barriers, and challenges around whether or not patients can bring their EHR data into prospective trials and what it means for patients.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
August 25, 2023

Wearables in Decentralized Trials

2023-04-15 Jennifer Price (THREAD) and Jeremy Wyatt (ActiGraph) joined our hosts Amir Kalali and Craig Lipset to discuss wearables and how they can be used in DCTs. Areas of focus were how to properly support the patient, interpreting the data, and the barriers in the adoption of wearables.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
August 18, 2023

What is the Financial ROI for Decentralized Trials?

2022-01-14 A whitepaper around research that helped quantify the ROI of Decentralized Trials inspired this conversation with Pamela Tenaerts and Andrew Mackinnon from Medable, alongside hosts Craig Lipset & Amir Kalali.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
August 11, 2023
View All Episodes

Decentralized: The Decentralized Trials & Research Podcast

Decentralized: The Decentralized Trials & Research Podcast is brought to you by the Decentralized Trials & Research Alliance (DTRA). This is a space for all who want to improve access for clinical research and participation. New topics are covered every week live on Clubhouse with guest speakers in the industry to talk about the latest ways to make research and clinical trials more inclusive, accessible, resilient, and sustainable by using decentralized methods.

Team

Craig Lipset

Craig Lipset

Craig Lipset (he/him/his) leads at the forefront of innovation in clinical research and medicine development. He is an advisor to technology and biopharmaceutical companies, leading universities, and the venture community, bringing vision and driving action at the intersection of research, digital solutions, and patient engagement. Craig was the Head of Clinical Innovation and Venture Partner at Pfizer, on the founding Operations Committee for TransCelerate Biopharma, and on the founding management teams for two successful startup ventures (Perceptive Informatics and Adnexus Therapeutics). During that time, Craig designed and launched multiple industry firsts -- from the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants.

He currently serves on the Board of Directors for the Decentralized Trials & Research Alliance (Co-Chair), Foundation for Sarcoidosis Research and the MedStar Health Research Institute, and, as well as on the Editorial Board for Therapeutic Innovation & Regulatory Science. Craig is an Adjunct Assistant Professor in Health Informatics at Rutgers University, and an Adjunct Instructor at the University of Rochester Center for Health + Technology.

Craig has received the red jacket 'hall of fame' recognition among the PharmaVOICE most inspiring people in the life sciences. He has been recognized among Pharmaceutical Executive’s Emerging Leaders, CenterWatch Top 20 Innovators in Clinical Trials, the Medicine Maker Power List and the AlleyWatch Who's Who in eHealth. He studied Music at Brandeis University and earned a Master of Public Health from Columbia.
Amir Kalali, MD

Amir Kalali, MD

Dr. Kalali is a physician-scientist, recognized globally as a leading innovator at the intersection of life sciences and technology, and a convener of collaborative high-impact forums. He is a board director of both private and publicly traded companies, and advises companies in the life sciences and technology sectors, universities, and investment groups. Dr. Kalali is the Co-Chair of the Decentralized Trials and Research Alliance (DTRA), Chairman and Chief Curator of the CNS Summit, a forum focused on the future of life sciences, and was the Founding Chairman, and sits on the Executive Committee of the International Society for CNS Drug Development (ISCDD), one of the first independent non-profits to bring together leaders in drug development to collaborate, and on the Executive Committee of the International Society for CNS Clinical Trials and Methodology (ISCTM).

He is a Professor of Psychiatry at the University of California San Diego, Editor of the journal Innovations in Clinical Neuroscience, and the Lead Editor of the book Essential CNS Drug Development., published by Cambridge University Press. He has authored over 250 peer-reviewed publications, and numerous book chapters. He has been involved in initiatives by the Institute of Medicine, as well as the NIH FAST and the NIH NCATS programs. Previously, for almost 20 years, he was the Global Head of the Neuroscience Center of Excellence at Quintiles, now known as IQVIA.

In this role, he led the enterprise-wide strategy for neuroscience, encompassing drug development and health care services. He was responsible for numerous successful drug development programs that have led to dozens of approved new treatments for patients. Dr. Kalali regularly speaks at national and international scientific meetings on topics including drug development, clinical trials, innovation, technology, digital medicine, biohacking, and health. Dr. Kalali’s contributions have been recognized by life sciences media including The Medicine Maker’s Power List and the PharmaVOICE magazine’s Inaugural Red Jacket award, recognizing those who have been most lauded by their peers

You may also like

Join our community and never miss
your favorite episodes

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners